anti-PD-L1 Affimer/STING agonist conjugate (Avacta)

N/A

Report date: 2025/01/26 19:25:24

Base Information

Drug Nameanti-PD-L1 Affimer/STING agonist conjugate (Avacta)
Drug Alias Namedual PD-L1 checkpoint inhibitor/STING agonist (Avacta)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionStimulator of interferon genes stimulantsProgrammed death-ligand 1 blockers
TargetsStimulator of interferon genesProgrammed death-ligand 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAvacta Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAvacta Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A